Rhythm Pharmaceuticals gains on report of an additional bidder
FROM THE WIRE · SEEKINGALPHA.COM
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA report of a second potential bidder can support the stock during an M&A process.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Rhythm Pharmaceuticals rises on a reported second bidder.
- 02The earlier offer came from AstraZeneca, at nearly $10B.
- 03The stock gained on the report.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets